Show Summary Details
Page of

Pharmacotherapy of Low Back Pain 

Pharmacotherapy of Low Back Pain
Chapter:
Pharmacotherapy of Low Back Pain
Author(s):

Kay Brune

and Bertold Renner

DOI:
10.1093/med/9780199558902.003.0134
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 July 2021

It becomes clear that LBP is and will remain a major health problem. There is little proven evidence of the therapeutic effects of many drugs and other treatments (Bouwmeester et al. 2009). In ALBP, only COX inhibitors, used cautiously, may help to regain mobility and social functions (Kroenke et al. 2009) which in turn allows for exercise that furthers recovery (Oesch et al. 2010).

As COX inhibitors lose effectiveness with time, opioids may step in. Their effect may be enhanced by co-medication with either muscle relaxants or antiepileptics. However, opioids + muscle relaxants or antidepressants show a high rate of UDEs. Most patients find these side effects intolerable which leads to a dropout-rate (in studies) around 50% (Kuijpers et al. 2010).

Obviously, the treatment of CLBP requires therapeutic planning and long-term therapy, including psychotherapy and physiotherapy as main pillars whilst the different drugs may be regarded as auxiliary.

The biggest problem is the inability of many patients to cope and wait. Some resort to remedies of unproven or even disproven value (effect), as herbal medicines, local steroids, topical non-steroidals, acupuncture, an injection therapy using steroids, etc., and surgical interventions. Whilst the former are unlikely to harm the patient seriously, attempts to inject into the fine zygapophysial joints and surgical interventions in patients who have no hard indication (nerve decay and paralysis) may add to the negative long-term outcomes of LBP.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.